PAN Foundation: MASH

Coverage RequiredFunded

About

The PAN Foundation MASH Fund provides copay assistance grants of up to $4,200 per year for government-insured patients (Medicare, Medicaid, or TRICARE) prescribed qualifying medications including Wegovy. Income limit is 500% FPL. Fund is currently OPEN and accepting applications.

Insurance requirements: Medicare / Medicaid

Enrollment Forms

PAN Foundation MASH Fund

Benefits

•$4200 annual maximum benefit

Program Requirements

•Valid only for residents in the US and Puerto Rico

•Enrollment Required: Yes

•Coverage Required: Yes

•Needs Based: Yes

•Activation Required: No

Program Details

•Initial grant up to $2,100, renewable up to $4,200 per year

•Covers copays for medications treating MASH including Wegovy (semaglutide)

•Income eligibility: household income at or below 500% Federal Poverty Level

•Must have governmentinsured coverage: Medicare, Medicaid, or TRICARE

•Commercially insured patients are NOT eligible for this fund

•US residency required; must receive treatment in the US or US territories

•Fund status: OPEN currently accepting new applications

•Also covers: Ozempic, Rybelsus, Mounjaro, Zepbound, Rezdiffra, Jardiance, Farxiga, Saxenda, Victoza

Let us handle your prior authsJust enter your patient's info and we'll:

Verify eligibility with the payer.
Pull the right PA forms directly from the payer.
Submit, track & send live updates to your dashboard.

Utilize patient records to autofill forms with our AI in seconds.

Free to start · HIPAA compliant

Enrollment Forms

PAN Foundation MASH Fund

Let us handle your prior authsJust enter your patient's info and we'll:

Verify eligibility with the payer.
Pull the right PA forms directly from the payer.
Submit, track & send live updates to your dashboard.

Utilize patient records to autofill forms with our AI in seconds.

Free to start · HIPAA compliant

Other Programs

HealthWell Foundation: MASH

Wegovy at no costSee program details for eligibility

NovoCare Pharmacy Home Delivery

Wegovy at no costSee program details for eligibility

Other Tools for Wegovy

Check medication interactions

Get prior authorization forms

Get patient education materials

Frequently Asked Questions (FAQ)

The Wegovy Savings Offer from Novo Nordisk lets eligible commercially insured patients pay as little as $25 per month, with savings up to $100 per month. Patients with Medicare or Medicaid coverage can't use the savings offer but may qualify for the HealthWell Foundation MASH or PAN Foundation MASH programs (Wegovy at no cost, eligibility-dependent). Open the program cards above for the option that matches your patient.

Yes — the Wegovy Savings Offer from Novo Nordisk. Eligible patients with commercial insurance pay as little as $25 per month, up to $100 per month in savings. Patients on Medicare or Medicaid aren't eligible for the savings offer but may qualify for the HealthWell Foundation MASH or PAN Foundation MASH program (Wegovy at no cost for eligible patients). See the program cards above for current terms.

PrescriberPoint surfaces Novo Nordisk's self-pay options for uninsured patients: the Wegovy Self-Pay Program for the oral tablet is as low as $149 per month, and the injectable self-pay program is as low as $349 per month. Commercially insured patients can use the Wegovy Savings Offer instead — as little as $25 per month, up to $100 per month in savings. Open the program cards above to compare every option for your patient.

There are paths for every coverage type. Commercially insured patients → Wegovy Savings Offer ($25/month, up to $100/month in savings). Medicare or Medicaid patients → HealthWell Foundation MASH or PAN Foundation MASH (no cost for eligible patients). Uninsured patients → Wegovy Self-Pay Program ($149/month oral tablet, $349/month injectable). The program cards above show each option with its eligibility and enrollment link.